Drivers
One of the key factors expected to stimulate market growth during the forecast period is the multiple applications of strontium bromide in pharmaceutical industry. In the pharmaceutical industry strontium bromide is used to treat bone related disorders such as osteoporosis. The strontium bromide is incorporated in the medicines to optimize bone resorption and bone formation, resulting in increased bone mass, which may be of great value in the treatment of osteoporosis.
The rising prevalence of bone related disorders is expected to drive the market for the global strontium bromide market. For instance, according to the report published by National Center for Biotechnology Information in March 2017, due primarily to the aging of the population in the North America region, the prevalence of osteoporosis and low bone mass is expected to increase, by 2020, one in two Americans over age 50 is expected to have or be at risk of developing osteoporosis of the hip will be at risk of developing osteoporosis even more at any site in the skeleton.
Market Restraints
The lack of growth opportunities available in the pharmaceutical industries associated with strontium bromide in the emerging economies, such as majority of African countries is expected to hamper the market. For instance, according to a United Nations report the growth of Africa's pharmaceutical sector as do poor procurement and supply chain systems and policy incoherencies in countries' trade, industry, health, and finance department's growth over the forecast period. Moreover, the side effects and health hazards caused due to exposure of strontium bromide such as skin irritation and eye irritation is also restraining the market growth. All this factors associated with the use of strontium bromide is expected to restrain the global strontium bromide market growth.
Strontium Bromide Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients